Guide · Updated November 2026

GLP-1 Medications and Anxiety: What Research Shows (2026)

Some people on GLP-1 medications describe new anxiety. Others say they feel calmer. The trial data so far does not show a higher rate of psychiatric problems. In January 2026 the FDA reviewed 91 placebo-controlled trials with 107,910 patients and found no increased risk of anxiety, depression, irritability, psychosis, or suicidal thoughts, and asked for the suicidality warning to be removed from Wegovy, Zepbound, and Saxenda labels. That does not mean no individual ever feels worse. Here is what the research shows and what to do if it happens to you.

The first month on Mounjaro, my relationship with food changed so fast it felt disorienting. I am someone who tracked macros and used food as a reward system after long days. When that switch flipped and food suddenly did not interest me the way it used to, I felt untethered. Not panicked, but unsettled in a way I was not prepared for. That experience is what pushed me to look into the research on GLP-1 medications and mental health.

The Two Camps: More Anxious vs. Less Anxious

If you spend any time reading about GLP-1 side effects online, you will notice something strange. Some people say these medications made their anxiety worse. Others say they feel calmer than they have in years. Both groups are telling the truth about their experience. The question is why.

Reports of increased anxiety on GLP-1 medications tend to cluster around a few common themes:

Early treatment. Many reports describe the first weeks, especially around dose increases, when side effects are also strongest.
Rapid appetite loss. People who relied on food as an emotional regulator suddenly lose that tool.
Physical side effects. Nausea, GI distress, and fatigue can all trigger or worsen anxiety, especially in people who already have an anxiety disorder.
Health anxiety. Starting a new injectable medication with a long list of potential side effects creates worry in some patients.

Reports of decreased anxiety tend to follow a different pattern:

Steadier blood sugar. In people with diabetes, GLP-1 medications reduce glucose spikes after meals. Some people link that to feeling steadier.
Weight loss confidence. As body composition improves, some people experience less social anxiety and better self-image.
Reduced food noise. The constant mental chatter about what to eat, when to eat, and guilt about eating fades. For some people, that is a big source of relief.
Less inflammation. GLP-1 medications lower some inflammation markers, and inflammation has been linked to depression in research. Whether this changes anxiety in people is not established.

The Food-Mood Connection: Losing Your Coping Mechanism

This is the part that does not get enough attention. For many people, food is not just fuel. It is a coping mechanism, a reward system, a way to manage stress and emotions. Comfort eating after a bad day, stress eating during deadlines, celebratory eating after wins. These patterns run deep.

GLP-1 medications can quiet that system quickly. Some people go from thinking about food constantly to having little interest in eating within the first weeks.

If food was your primary emotional coping tool, suddenly losing it can feel like having the rug pulled out. You still feel the stress, the boredom, the frustration. But the thing you always reached for is no longer appealing. That gap between the emotional trigger and the missing response can produce real anxiety.

This is not a character flaw. Removing a coping mechanism without replacing it can leave a gap. This explanation is plausible but has not been tested well in GLP-1 users. Until new coping tools are in place, that gap can feel like anxiety.

I noticed this in my own experience. Evenings were the hardest. I used to unwind with a good meal after work. When that stopped feeling rewarding, I had to find other ways to decompress. Walking, reading, calling a friend. They work, but the transition was not smooth.

Blood Sugar Stabilization and Mood

Blood sugar is one possible link between GLP-1 medications and anxiety, in both directions.

Low blood sugar triggers adrenaline release, which can cause a racing heart, sweating, and shakiness that feel a lot like a panic attack. The Wegovy and Zepbound labels list anxiety, irritability, or mood changes among the signs of low blood sugar. That risk is mainly for people who also take insulin or a sulfonylurea. If you take one of those and feel sudden anxiety, check your blood sugar and follow your prescriber’s low blood sugar plan.

On the other side, GLP-1 medications slow gastric emptying and reduce glucose spikes after meals. Some people feel steadier as a result, but trials have not measured this as an anxiety outcome.

Key point: if anxious spells line up with skipped meals, mention that pattern to your prescriber. If your anxiety is more situational or long-standing, blood sugar is unlikely to be the main driver.

GLP-1 Receptors in the Brain

GLP-1 is not just a gut hormone. GLP-1 receptors are found in the brain, including regions involved in stress, reward, and appetite. Most of what we know about their role in mood comes from animal studies.

The key brain areas with GLP-1 receptor expression include:

Amygdala: The brain’s threat-detection center. Animal studies suggest GLP-1 signaling here can affect fear and anxiety-like behavior.
Hippocampus: Involved in memory and stress regulation. Animal studies suggest GLP-1 receptor agonists may protect nerve cells here.
Hypothalamus: Controls appetite and the stress hormone response. In animals, GLP-1 signaling here can influence stress hormones.
Nucleus accumbens: Part of the reward circuit. In rats, semaglutide reached this area and reduced alcohol intake, which is one reason researchers think these drugs may affect cravings.

Animal research on anxiety is mixed. Some rodent studies show less anxiety-like behavior with GLP-1 receptor agonists, and others show more, depending on the drug, dose, and test.

The catch: animal models of anxiety do not translate perfectly to human experience. Rodents do not have complicated relationships with food, body image concerns, or health anxiety about injecting a new medication. The human experience includes psychological and social factors that animal models cannot capture.

Looking for a GLP-1 provider that includes mental health support?

Compare Providers →

What Clinical Trials Actually Show

Clinical trial data on psychiatric side effects of GLP-1 medications is limited but worth examining.

Source	Medication	Psychiatric Findings
Pooled STEP 1, 2, 3 and 5 analysis (JAMA Internal Medicine, 2024)	Semaglutide 2.4mg	No increase in depressive symptoms or suicidal ideation. Psychiatric adverse events generally balanced with placebo
FDA review (January 2026)	GLP-1 RAs including semaglutide and tirzepatide	91 trials, 107,910 patients. No increased risk of suicidal thoughts, anxiety, depression, irritability, or psychosis
EMA PRAC review (April 2024)	Semaglutide, liraglutide, and other GLP-1 RAs	Evidence does not support a causal link to suicidal thoughts
Wegovy label, adolescent trial	Semaglutide 2.4mg	Anxiety reported in 4% on Wegovy vs 2% on placebo

The FDA review is the largest look so far. It also included a health-records study of more than 2.2 million new users of GLP-1 drugs or a comparison diabetes drug. In the adult STEP trials, the pooled analysis found a small drop in depression scores on semaglutide that the authors did not consider clinically meaningful.

But here is the limitation. Clinical trials use structured questionnaires and predefined adverse event categories, and most excluded people with serious mental illness. Mild-to-moderate anxiety that does not meet diagnostic criteria often goes unreported. A patient who feels “more on edge” but does not describe it as anxiety to their study coordinator will not show up in the data. This is the same gap we see with fatigue reporting.

Patients also file voluntary reports of anxiety to the FDA Adverse Event Reporting System (FAERS). Those reports have major limitations (self-reported, no denominator, reporting bias) and cannot show that a drug caused a symptom.

Body Image Shifts During Rapid Weight Loss

Rapid weight loss creates its own psychological challenges, and GLP-1 medications can produce weight loss faster than most people have experienced before.

Losing 15% to 20% of body weight over a year or so changes how you look, how clothes fit, how people treat you, and how you see yourself. For some people, this is straightforwardly positive. For others, it creates unexpected anxiety.

Common psychological responses to rapid weight loss include:

Identity disruption. If you have been overweight for years or decades, your body is part of your identity. Rapid change can feel destabilizing.
Unwanted attention. Compliments about weight loss can feel uncomfortable, especially when they imply your previous body was a problem.
Loose skin and body dissatisfaction. Losing weight does not always mean liking what you see. Some people trade one body image concern for another.
Fear of regain. Knowing that most diets fail, and reading about post-GLP-1 weight regain, creates anxiety about maintaining results.
Disordered eating patterns. The line between “I am not hungry” and “I should not eat” can blur, especially in people with a history of restrictive eating.

I went through some of this. My DEXA scan data showed I was losing weight faster than expected. That should have been good news, but I started worrying about whether I was losing too much muscle, whether I would end up with loose skin, whether the weight would come back if I ever stopped the medication. Tracking body composition helped ground me in data instead of anxiety.

When to Talk to Your Provider

Not all anxiety on GLP-1 medications needs medical intervention. Some adjustment-period unease is normal and resolves on its own. But there are clear signals that you should bring it up with your prescriber.

Talk to your provider if:

Anxiety is new and started after beginning the medication or increasing your dose
You are having panic attacks for the first time
Anxiety is interfering with daily functioning (work, relationships, sleep)
You notice changes in mood that feel out of proportion to your circumstances
You have a history of anxiety or depression and things are getting worse
You are having intrusive thoughts about food, body image, or self-harm

What your provider might do:

Adjust dose timing or slow the titration schedule
Recommend therapy, particularly cognitive behavioral therapy (CBT), which has strong evidence for anxiety
Screen for other causes (thyroid function, blood sugar, nutrient deficiencies, sleep disorders)
Consider whether a different medication would suit you better
Add or adjust psychiatric medication if appropriate

Do not wait for your next scheduled appointment if anxiety is severe. Most telehealth GLP-1 providers have messaging systems for between-visit concerns. If you have thoughts of harming yourself, call or text 988 (in the US) or go to the nearest emergency room.

Practical Steps if You Are Feeling Anxious on GLP-1s

Based on both the research and conversations across patient communities, here is what tends to help:

1. Replace the coping mechanism. If food was your stress relief, you need a substitute. Exercise, therapy, meditation, social connection, creative outlets. Pick one and commit to trying it for two weeks.

2. Track your mood alongside your medication. Note your dose, injection day, and anxiety levels daily (even just a 1 to 10 scale). Patterns are easier to discuss with your prescriber when you have notes.

3. Stabilize your eating. Even if you are not hungry, eat regular small meals with protein. Going many hours without food can leave you shaky and on edge, and it raises low blood sugar risk if you take insulin or a sulfonylurea.

4. Move your body. Regular exercise has good evidence for easing anxiety symptoms, and it also helps protect muscle during weight loss. Even a 20-minute walk counts.

5. Consider therapy. If you have never worked with a therapist, this is a good time to start. The psychological adjustment to GLP-1 medications is real, and a therapist can help you build new coping strategies. CBT and acceptance and commitment therapy (ACT) both have strong evidence for anxiety.

6. Connect with others going through it. The subreddits r/Mounjaro and r/Ozempic have active communities where people discuss mood changes openly. Forums are not medical advice, but they can help you feel less alone.

7. Get your labs checked. Thyroid function, B12, vitamin D, and iron can all affect anxiety levels. If you are eating significantly less food, nutrient deficiencies become more likely. Simple blood work can rule these out. At-home kits like myLab Box cover thyroid and metabolic panels without a clinic visit.

The Bottom Line

GLP-1 medications act on the brain, not just the gut. Large reviews have not found more anxiety on these drugs than on placebo, but individual experiences vary. For some people the net effect is positive, with reduced food noise and steadier blood sugar leading to a calmer baseline. For others, losing a primary coping mechanism and going through rapid physical changes creates genuine psychological distress.

Neither response is wrong. Both are worth paying attention to. If you are experiencing anxiety on a GLP-1 medication, track it, talk to your provider about it, and do not assume you just need to push through. Mental health is part of the treatment picture, and any provider worth working with will take it seriously.

For more on managing side effects, check the full GLP-1 side effects guide.

FAQ

Can GLP-1 medications cause anxiety?

Yes, some patients report new or increased anxiety on GLP-1 medications like semaglutide and tirzepatide. A 2026 FDA review of 91 placebo-controlled trials found no increased risk of anxiety. Trials may miss milder symptoms, though. Possible causes include losing food as a coping tool, physical side effects, and rapid body changes.

Do GLP-1 medications help with anxiety?

Some people say they feel calmer, often because food noise fades. GLP-1 medications are not approved or proven to treat anxiety. A pooled analysis of semaglutide trials found a small drop in depression scores that the authors did not consider clinically meaningful.

Should I stop my GLP-1 medication if I feel anxious?

Do not stop without talking to your prescriber. Mild unease during the early weeks may settle as side effects ease. If anxiety is severe, persistent, or interfering with daily life, your provider may adjust the dose, slow titration, or recommend additional support like therapy or medication.

Is anxiety a listed side effect of Ozempic or Mounjaro?

Anxiety is not listed as a common side effect in the Ozempic or Mounjaro prescribing information. The labels do list anxiety as a possible sign of low blood sugar, mainly a risk with insulin or sulfonylureas. The Wegovy label reports anxiety in 4% of adolescents on Wegovy versus 2% on placebo.

There is no good data on a typical timeline. Many people say early unease eases as nausea and other side effects settle and new routines form. If anxiety lasts more than a few weeks, gets worse, or affects daily life, talk to your provider.

Guides:

Medications:

Mounjaro (Tirzepatide) Guide

Tools:

Reviews:

What we checked

This AI-assisted public-source desk check reviewed the January 2026 FDA drug safety communication on GLP-1 psychiatric safety, the pooled STEP psychiatric safety analysis in JAMA Internal Medicine, the April 2024 EMA safety committee highlights, the 2023 eBioMedicine animal study, and the Wegovy and Zepbound FDA labels on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.